Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor Sakiyeva Kanshaiym, Gulmira Zhurabekova, Ibrahim A. Abdelazim, Tatyana Starchenko

BENEFITS OF USING FERRIC CARBOXIMALTOSE IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA RM Quijano, NLL Dornelles, K Rettig, V Diaz, J Ferrari

The cause of very severe trombocytosis: iron deficiency anemia V. Uzel, S. SavaŞ, M. Soker